Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Terminated 1Recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 17Thoracic 2Genitourinary 2Gastrointestinal 2Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 86Lung Neoplasms 32Small Cell Lung Carcinoma 18Melanoma 17Mesothelioma 13Neoplasms 11Colorectal Neoplasms 9Carcinoma, Renal Cell 9Squamous Cell Carcinoma of Head and Neck 7Neoplasm Metastasis 7Mesothelioma, Malignant 7Carcinoma, Transitional Cell 7Ovarian Neoplasms 6Diabetes Mellitus, Insulin-Dependent, 12 6Urinary Bladder Neoplasms 5Triple Negative Breast Neoplasms 5Pancreatic Neoplasms 5Liver Neoplasms 5Endometrial Neoplasms 5Carcinoma, Hepatocellular 5Uterine Cervical Neoplasms 4Stomach Neoplasms 4Kidney Neoplasms 4Brain Neoplasms 4Carcinoma, Merkel Cell 3Skin Neoplasms 2Sarcoma 2Prostatic Neoplasms 2Lung Diseases 2Head and Neck Neoplasms 2

Interventions

pembrolizumab 4Nivolumab 4Ipilimumab 2Interleukin-2 2Drug Therapy 2Biopsy 2poly ICLC 1pertuzumab 1osimertinib 1montanide ISA 51 1liposomal doxorubicin 1cobimetinib 1cemiplimab 1cc-486 1brodalumab 1atezolizumab 1Trastuzumab 1Tissue Banks 1Standard of Care 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiotherapy 1Quality of Life 1Psychiatric Rehabilitation 1Poly I-C 1Patient Reported Outcome Measures 1Paclitaxel 1Oxaliplatin 1Observation 1Molecular Diagnostic Techniques 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Skin Neoplasms × Ipilimumab × Thoracic × Clear all
NCT06362369 2026-04-13

A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

7 Hills Pharma, LLC

Phase 1/2 Recruiting
126 enrolled
DermatologicGastrointestinalGenitourinaryOther solid neoplasmThoracic

Turcot syndrome, Mesothelioma, Malignant, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Melanoma, Neoplasm Metastasis, Skin Neoplasms, Colorectal Neoplasms

NCT04311710 2023-02-24

CheckMate 76U

Bristol-Myers Squibb

Phase 1 Terminated
21 enrolled
DermatologicGastrointestinalGenitourinaryThoracic

Urinary Bladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Neoplasms, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡